Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
12.73
+0.21 (1.68%)
Oct 15, 2026, 12:10 PM EDT - Market open

Generate Biomedicines Revenue

Generate Biomedicines had revenue of $6.31M in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $26.48M. In the year 2025, Generate Biomedicines had annual revenue of $31.89M with 55.89% growth. That makes Generate Biomedicines the 32,122nd largest company in the world by revenue and 4,245th in the United States.

Revenue (ttm)
$26.48M
Revenue Growth
+55.89%
P/S Ratio
61.75
Revenue / Employee
$84,881
Employees
312
Market Cap
1.63B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202531.89M11.43M55.89%
Dec 31, 202420.46M--